Wed, March 22, 2023
Tue, March 21, 2023
Mon, March 20, 2023
Sat, March 18, 2023
Fri, March 17, 2023
Thu, March 16, 2023
Wed, March 15, 2023
Tue, March 14, 2023

Tiago Fauth Reiterated (SPRB) at Buy and Held Target at $4 on, Mar 17th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-4-on-mar-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tiago Fauth of Credit Suisse, Reiterated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $4 on, Mar 17th, 2023.

Tiago has made no other calls on SPRB in the last 4 months.



There are 2 other peers that have a rating on SPRB. Out of the 2 peers that are also analyzing SPRB, 0 agree with Tiago's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tiago


  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Monday, February 13th, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $8 on, Thursday, November 17th, 2022

Publication Contributing Sources